Hewatele

About Hewatele

Hewatele is a Kenyan social enterprise founded in 2014 by the Center for Public Health and Development (CPHD). Its mission is to provide a regular supply of medical oxygen at affordable rates to reduce delays in access to emergency healthcare, with a vision to make oxygen an essential part of emergency healthcare at all levels of facilities in Sub-Saharan Africa.

Products & Services

Medical Oxygen Solutions:Provision of medical oxygen supply to healthcare facilities to ensure accessibility and affordability in emergency care.

Specialties

Medical Oxygen Supply Emergency Healthcare Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt and Equity T: - FT: Debt and Equity	A: 20000000 MR: - FA: USD 20 million FAN: 20000000	D: 2024-03-06 FD: 2024-03-06	5 investors

Debt and Equity Latest

2024-03-06

$20.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

Wali Zulfiqar

Chief Executive Officer

J

Joan Andia

Chief Finance Officer

A

Ann Mbuve

Human Resources Manager

R

Rita Wairimu Ndonye

Head of Safety, Health, Environment and Quality

J

Joanes Muga

Chief Technology Officer

O

Opot Hannington

Business Development Manager

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Hewatele Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised